GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Emcure Pharmaceuticals EMCURE.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

2,216.20

+0.15%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹92.04bn

FY2022FY2026

Net income

₹9.24bn

FY2022FY2026

Free cash flow

₹4.90bn

FY2022FY2026

Shareholders' equity

₹49.50bn

FY2022FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022
Revenue₹92.04bn₹78.08bn₹65.82bn₹59.31bn₹57.66bn
Operating income₹13.74bn₹12.61bn₹9.17bn₹9.41bn₹11.24bn
Net income₹9.24bn₹6.81bn₹4.98bn₹5.32bn₹6.62bn
Diluted earnings per share48.7435.9426.3228.1334.91

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022
Total assets₹96.12bn₹82.33bn₹78.06bn₹66.73bn₹60.63bn
Cash and short-term investments₹2.16bn₹1.98bn———
Total liabilities₹46.36bn₹35.91bn₹46.84bn₹40.23bn₹39.49bn
Debt₹15.21bn₹10.23bn₹7.67bn₹7.44bn₹7.17bn
Shareholders' equity₹49.50bn₹44.46bn₹29.52bn₹25.01bn₹19.88bn
Shares outstanding190m190m189m189m190m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022
Cash from operations₹8.51bn₹8.52bn₹10.97bn₹7.47bn₹7.68bn
Capital spending−₹3.61bn−₹4.07bn−₹3.07bn−₹4.03bn−₹3.97bn
Free cash flow₹4.90bn₹4.45bn₹7.90bn₹3.43bn₹3.71bn
Dividends paid−₹568.5m—−₹542.5m−₹361.7m−₹542.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹25.80bn₹24.70bn₹23.63bn₹22.70bn₹21.01bn₹20.29bn₹19.63bn₹20.02bn
Operating income₹3.98bn₹3.79bn₹3.55bn₹3.34bn₹3.04bn₹2.93bn₹2.65bn₹2.84bn
Net income₹2.94bn₹2.43bn₹2.31bn₹2.43bn₹2.07bn₹1.89bn₹1.54bn₹1.95bn
Diluted earnings per share15.5012.8312.1612.8410.929.978.1210.28
Cash from operations———₹2.56bn—₹4.91bn——
Capital spending———−₹1.29bn—−₹1.12bn——
Free cash flow———₹1.27bn—₹3.80bn——
Total assets—₹96.12bn—₹93.93bn—₹82.33bn—₹81.24bn
Cash and short-term investments—₹2.16bn—₹6.02bn—₹1.98bn—₹3.32bn
Debt—₹12.59bn—₹13.84bn—₹7.65bn—₹9.72bn
Shareholders' equity—₹49.50bn—₹47.43bn—₹44.46bn—₹41.18bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue16.4%——
Operating income13.5%——
Net income20.2%——

Valuation history

At each fiscal year end

FY2026FY2025FY2024
Price to earnings45.038.054.9
Price to sales4.63.44.3

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 14 Aug 2025.

FY2026
Paid in the year3.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.